Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene Editing Therapy in Cardiovascular Disease: 2026 ACC Scientific Statement: A Report of the American College of Cardiology.

Journal of the American College of Cardiology·2026
Same author

Atrial FDG avidity is associated with reduced atrial strain and contractility independent of atrial fibrillation and cardiac sarcoidosis.

European heart journal. Imaging methods and practice·2026
Same author

Structuring telemonitoring in heart failure care in The Netherlands: design and operational protocol of a nationwide initiative.

European heart journal. Digital health·2026
Same author

Atrial <sup>18</sup>FDG Uptake Predicts Incident Atrial Fibrillation in Patients Undergoing Cardiac PET Imaging.

JACC. Advances·2026
Same author

Clinical, Echocardiographic, and Socioeconomic Predictors of Progression and Outcomes in Patients With Moderate Aortic Stenosis.

Echocardiography (Mount Kisco, N.Y.)·2025
Same author

Non-Invasive Remote Monitoring in Heart Failure: Towards Wearable Devices and Artificial Intelligence Solutions : Short Title: Remote Monitoring and Wearable Devices in Heart Failure.

Current heart failure reports·2025

Related Experiment Video

Updated: Jun 16, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Smart Technology, Fragile Hearts: Navigating AI's Challenges and Limitations in Heart Failure Management.

Paul Nona1, Juma Bin Firos2, Carrie Zografos3

  • 1Department of Cardiology, Michigan Heart & Vascular Institute, IHA Medical Group, Trinity Health, Livonia, MI, USA. Paul_Nona@michiganheart.com.

Current Heart Failure Reports
|June 15, 2026
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) shows promise in heart failure care, but challenges like data issues and bias hinder its clinical use. Safeguards are crucial for safe and equitable AI implementation in medicine.

Keywords:
Algorithmic biasArtificial intelligenceData qualityElectronic health recordsHeart failureMachine learning

Related Experiment Videos

Last Updated: Jun 16, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Area of Science:

  • Cardiology
  • Medical Informatics
  • Artificial Intelligence

Background:

  • Artificial intelligence (AI) is increasingly explored for applications in heart failure (HF) management.
  • These applications span phenotyping, risk stratification, medical imaging interpretation, and point-of-care decision support.

Purpose of the Study:

  • To review advancements in AI for heart failure care.
  • To identify barriers to the safe and equitable clinical translation of these AI tools.

Main Methods:

  • Systematic review of recent literature on AI applications in heart failure.
  • Synthesis of findings on AI performance, limitations, and implementation challenges.

Main Results:

  • Heterogeneous and incomplete clinical data, model opacity, and evolving healthcare landscapes pose significant challenges.
  • Underrepresentation in datasets and outcome misclassification can exacerbate health disparities.
  • Lack of continuous monitoring and inconsistent regulatory frameworks impede validation and trust.

Conclusions:

  • Robust evaluation, transparent reporting, and continuous monitoring are essential for safe AI deployment.
  • Mitigation strategies include rigorous data curation, bias auditing, and embedded human oversight.
  • Priorities include robust evaluation, surveillance for AI performance drift, and alignment with patient-centered outcomes.